文献速递消化内镜消化道肿瘤与早癌消化道出血

纤维蛋白胶预防胃内镜黏膜下剥离术后出血的随机对照试验

A Randomized Controlled Trial of Fibrin Glue to Prevent Bleeding After Gastric Endoscopic Submucosal Dissection.
PubMed 文献 · Am J Gastroenterol · 2022-12-30

这项在韩国4家三级医疗中心开展的多中心、开放标签、随机对照试验,于2020年7月1日至2022年6月22日纳入胃肿瘤且ESD术后出血高风险患者,按1:1分为标准ESD对照组和标准ESD后纤维蛋白胶组。主要结局4周内总体出血事件两组无显著差异(纤维蛋白胶组12.0% vs 对照组13.1%,P=0.791),但纤维蛋白胶组急性出血事件显著少于对照组(1/125 vs 7/122,P=0.034),迟发出血两组无显著差异(11.2% vs 7.3%,P=0.301)。

要点

  • 在高风险患者中,纤维蛋白胶未能预防ESD术后4周内总体出血。
  • 纤维蛋白胶组急性出血(48小时内)显著少于对照组(1/125 vs 7/122,P=0.034)。
  • 迟发出血(48小时至4周)两组无显著差异(11.2% vs 7.3%,P=0.301)。

核心结论

  • 本试验未能显示纤维蛋白胶对高风险患者ESD术后总体出血的预防效果,但次要结局提示纤维蛋白胶在急性期可能具有封堵效应。

研究设计与样本

  • 多中心、开放标签、随机对照试验,在韩国4家三级医疗中心于2020年7月1日至2022年6月22日开展。
  • 纳入胃肿瘤且ESD术后出血高风险(预期医源性溃疡大小≥40 mm或接受抗血栓治疗)的患者,按1:1分配至对照组(标准ESD)或纤维蛋白胶组(标准ESD后于医源性溃疡涂抹纤维蛋白胶)。
  • 共随机254例,改良意向治疗人群247例(纤维蛋白胶组125例,对照组122例)。

主要发现

  • 4周内总体出血事件:纤维蛋白胶组12.0%(15/125) vs 对照组13.1%(16/122),P=0.791。
  • 急性出血事件(ESD术后48小时内):纤维蛋白胶组1/125 vs 对照组7/122,P=0.034。
  • 迟发出血事件(ESD术后48小时至4周):纤维蛋白胶组11.2%(14/125) vs 对照组7.3%(9/122),P=0.301。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study evaluated the efficacy of fibrin glue for preventing postendoscopic submucosal dissection (ESD) bleeding in high-risk patients for bleeding (expected iatrogenic ulcer size ≥40 mm or receiving antithrombotic therapy). METHODS: A multicenter, open-label, randomized controlled trial was performed at 4 tertiary medical centers in South Korea between July 1, 2020, and June 22, 2022. Patients with gastric neoplasm and a high risk of post-ESD bleeding were enrolled and allocated at 1:1 to a control group (standard ESD) or a fibrin glue group (fibrin glue applied to iatrogenic ulcers after standard ESD). The primary outcome was overall bleeding events within 4 weeks. The secondary outcomes were acute bleeding (within 48 hours post-ESD) and delayed bleeding (48 hours to 4 weeks post-ESD). RESULTS: In total, 254 patients were randomized, and 247 patients were included in the modified intention-to-treat population (125 patients in the fibrin glue group and 122 patients in the control group). Overall bleeding events occurred in 12.0% (15/125) of the fibrin glue group and 13.1% (16/122) of the control group ( P = 0.791). Acute bleeding events were significantly less common in the fibrin glue group than in the control group (1/125 vs 7/122, P = 0.034). Delayed bleeding events occurred in 11.2% (14/125) in the fibrin glue group and 7.3% (9/122) in the control group ( P = 0.301). DISCUSSION: This trial failed to show a preventive effect of fibrin glue on overall post-ESD bleeding in high-risk patients. However, the secondary outcomes suggest a potential sealing effect of fibrin glue during the acute period.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lee HD, Lee E, Kim SG, et al. A Randomized Controlled Trial of Fibrin Glue to Prevent Bleeding After Gastric Endoscopic Submucosal Dissection. Am J Gastroenterol. 2022. PMID: 36594814. doi:10.14309/ajg.0000000000002172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。